Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " September 19, 2012":" October 19, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
Conditions: Cryptococcal Meningitis;   HIV
Interventions: Drug: Fluconazole;   Drug: Flucytosine;   Procedure: lumbar punctures
22 Completed Observational Study of Male Circumcision Using PrePex Device
Condition: HIV
Intervention: Device: PrePex device for male circumcision
23 Recruiting Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men
Condition: HIV
Interventions: Behavioral: MEN Count;   Behavioral: Comparison
24 Completed Safety and Efficacy of the PrePex Device Circumcision When Performed by Nurses
Conditions: Circumcision Adult;   HIV CDC Category B2
Intervention: Device: PrePex™ device
25 Terminated Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women
Conditions: HIV Infected Women;   Healthy Women Volunteers
Intervention: Procedure: vaginal swabs by washing and cytobrush
26 Recruiting SANKOFA Pediatric HIV Disclosure Intervention
Condition: HIV
Interventions: Behavioral: Disclosure intervention;   Behavioral: Enhanced usual care
27 Completed Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals
Condition: HIV
Interventions: Biological: 0-24 week prime/boost regimen;   Biological: 0-8 week prime/boost regimen
28 Completed Re-boosting of HIV-1 Infected Subjects With Vacc-4x
Condition: HIV-1 Infection
Intervention: Biological: Vacc-4x
29 Recruiting Rifampin and Efavirenz Interactions in Older Children
Conditions: HIV;   Tuberculosis
30 Unknown  A Pilot Study to Assess the Feasibility of Switching, Individuals Receiving Atripla With Continuing Central Nervous System (CNS) Toxicity, to a Fixed Dose Combination of Tenofovir/Emtricitabine/Rilpivirine
Condition: HIV
Intervention: Drug: tenofovir/emtricitabine/rilpivirine
31 Active, not recruiting Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events
Conditions: HIV;   Malnutrition;   Cryptosporidiosis
32 Recruiting Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan
Condition: HIV
33 Completed A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique
Conditions: Vaccines;   HIV;   Safety;   Immunogenicity
Interventions: Biological: HIVIS DNA vaccine;   Device: Zetajet;   Device: Derma Vax Electroporation;   Biological: Modified Vaccinia Ankara (MVA-CDMR)
34 Completed
Has Results
Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients
Condition: HIV, Pediatric
Interventions: Drug: Atazanavir;   Drug: Ritonavir
35 Completed Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men.
Condition: HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men
Intervention: Drug: Eviplera = emtricitabine 200mg, rilpivirine 25mg, tenofovir 245mg
36 Recruiting Varenicline for Nicotine Dependence Among Those With HIV/AIDS
Condition: Nicotine Dependence
Interventions: Drug: Varenicline;   Drug: Placebo;   Behavioral: Smoking Cessation Counseling
37 Unknown  Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Conditions: Neoplasms, Squamous Cell;   Papillomavirus Infections
38 Recruiting Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
Conditions: AIDS;   Tuberculosis
Intervention: Drug: Lopinavir/ritonavir and ritonavir
39 Recruiting Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders
Conditions: Sexually Transmitted Diseases;   Unsafe Sex;   Substance-Related Disorders
Interventions: Behavioral: PACT;   Behavioral: TAU
40 Withdrawn Prospective Study of Lymphoproliferative Diseases
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Lymphoma

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years